Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05055141 · ClinicalTrials.gov registry record · NA
Enhancing Caregiver Empathy by Empowering Patients to Discuss Their Values
A NA study of No Condition is the Focus of the Study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 539
- Enrollment target
- 1
- Study location
NCT05055141: Completed NA study of No Condition is the Focus of the Study, sponsored by The Cleveland Clinic.
NCT05055141 is a NA study of No Condition is the Focus of the Study that has completed, run by The Cleveland Clinic. The registered enrollment target is 539 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05055141, a NA study of No Condition is the Focus of the Study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 539 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the ENHANCE study was to determine if an intervention focused on empowering medical inpatients to discuss their values and interests with their Cleveland Clinic Caregivers leads to greater caregiver empathy, improved patient experience, and improved Caregiver experience. The intervention patient participants received a poster where they were able to share things about themselves that they wanted their Caregivers to know. These posters were hung on the wall behind their bed. A few days later, they were given a survey to assess their experiences in the hospital. On the control floors, medicine patients were recruited a few days into their admission and administered a survey. CCF Caregivers completed surveys before the intervention period and afterward. Data collection is complete, data analysis is largely finished and a manuscript is in progress. 320 patients and 219 CCF Caregivers participated in the study.
Primary Outcome
Patients' perceived empathy of their hospitalist is measured using 5 items with a 7 point Likert scale. Scores range from 5-35, with a higher score meaning patients perceive their physician as more empathic.
Conditions Studied
Interventions
- OTHER Care to Share poster
Study Locations (1)
Ohio
- Cleveland Clinic Main Campus Hospital - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 539 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2019-10-10 |
| Phase | NA |
What the finished NCT05055141 record still lists
NCT05055141 is an interventional study that assigns participants to a tested intervention. The registered 539 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower).
The record links to 1 condition, with No Condition is the Focus of the Study appearing as the primary indexed condition, and to 1 intervention - of which Care to Share poster is the first listed.
NCT05055141 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05055141 about?
NCT05055141 is a clinical study titled "Enhancing Caregiver Empathy by Empowering Patients to Discuss Their Values". The aim of the ENHANCE study was to determine if an intervention focused on empowering medical inpatients to discuss their values and interests with their Cleveland Clinic Caregivers leads to greater caregiver empathy, improved patient experience, and improved Caregiver experience. The intervention ...
What is the current status of trial NCT05055141?
This trial is currently completed. It is a NA study. The enrollment target is 539 participants. The study started on 2018-12-12. Estimated completion is 2019-10-10.
What conditions does trial NCT05055141 study?
This clinical trial studies the following conditions: No Condition is the Focus of the Study.
What interventions are being tested in trial NCT05055141?
The interventions under investigation include: Care to Share poster (OTHER).
Who is sponsoring clinical trial NCT05055141?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05055141 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05055141's enrollment target sits among peer trials
539 188th of 2000 higher than 1,813 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05429892 · 540 participants · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI